BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS




Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte 

Maxygen, Inc. 

Intergen Company 





 Company News
Novo Nordisk A/S (NVO)'s $225 Million Hemophilia Facility Will Create 100 New Jobs 5/4/2015 7:27:34 AM
Novo Nordisk A/S (NVO) CEO Candidate Abruptly Departs and Company Starts Hunt Afresh 4/30/2015 6:01:39 AM
Novo Nordisk A/S (NVO) Announces Saxenda (Liraglutide [Rdna Origin] Injection) Is Now Commercially Available In The United States 4/22/2015 11:29:43 AM
Novo Nordisk A/S (NVO) Celebrates World Hemophilia Day And Shares New Support Programs, Including HeroPath And Career Counseling 4/17/2015 10:34:45 AM
Novo Nordisk A/S (NVO) Extends Programme For Children With Diabetes In Developing Countries 4/15/2015 2:13:16 PM
Novo Nordisk A/S (NVO) Soars on Plans to Resubmit NDAs of Tresiba and Ryzodeg in U.S. 3/27/2015 7:18:30 AM
Bristol-Myers Squibb (BMY) Acquires Exclusive License From Novo Nordisk A/S (NVO) For A Discovery Research Program Focused On Autoimmune Diseases 3/24/2015 10:37:29 AM
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015 10:08:01 AM
Novo Nordisk A/S (NVO) Release: New Data In Adults With Obesity Or Who Are Overweight With Comorbidities Losing At Least 5% Body Weight With Saxenda (liraglutide [rDNA origin] injection) Showed Improvement In Blood Glucose, CV Risk Factors And Quality Of Life Outcomes 3/9/2015 6:38:22 AM
Novo Nordisk A/S (NVO) Named On The 2015 FORTUNE 100 Best Companies To Work For List For Seventh Consecutive Year 3/5/2015 12:02:36 PM
12345678910...